Clinical Trial

Statin-Intolerance Registry

Study acronym: SIR
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The Statin-Intolerance Registry will characterize the patient population suffering from statin-intolerance which is a frequent but incompletely understood patient condition with important clinical implications for atherosclerotic cardiovascular disease (ASCVD) prevention. Patients will be systematically and prospectively included and followed by the registry.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-07-14; most recent amendment 2026-02-15.
Status change: Recruiting → Active, Not Recruiting 2024-02-27
Status change: Not Yet Recruiting → Recruiting 2021-09-28
Trial Details
NCT Number NCT04975594
Lead Sponsor University of Leipzig
Collaborators: University of Jena, University Hospital Dresden, Charite University, Berlin, Germany
Conditions Dyslipidemias
Enrollment 1,000 participants
Start Date 2021-08-01
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-17